Does basal phenotype identify a poor prognostic subgroup of breast cancer of clinical importance?
Our results provide robust evidence that BP is an important class of breast cancers with a particularly aggressive behaviour in patients with LN negative grade 3 disease. We recommend routine identification of BP in breast cancer and the development of effective adjuvant treatment strategies. These are important observations as these tumours typically lack hormone receptor and HER-2 overexpression limiting the range of relevant adjuvant therapies.
Micturition and phase III of the migrating motor complex are associated in time.